Global Metoprolol Tartrate Market, by Route Of Administration (Tablets and Injectable), by Application (Hypertension, Cardiovascular, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 6,101.4 Mn in 2022 and is expected to exhibit a CAGR of 3.3% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing prevalence of angina, a type of chest pain is expected to drive the global metoprolol tartrate market over the forecast period. For instance, in 2021, an article published in the Jama Network journal, which is a database of scientific references stated about the prevalence of angina among primary care patients with coronary artery disease that around 21.2% of patients experienced angina at least once monthly. Angina symptoms can be assessed in advance using established techniques, and people at higher risk can be identified and treated with medications, reducing morbidity.
Global Metoprolol Tartrate Market – Impact of Coronavirus (COVID-19) Pandemic
The most recent epidemic is the coronavirus (COVID-19) pandemic, which was initially detected on December 31, 2019, in Wuhan, China. COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. According to the World Health Organization's Coronavirus Illness (COVID-19) Epidemiological Update, coronavirus disease (COVID-19) caused approximately 426 million cases and 5,899,578 fatalities in the worldwide till 20 February 2022.
Furthermore, increasing impact of COVID-19 on cardiovascular diseases is expected to drive the global metoprolol tartrate market over the forecast period. For instance, on April 21, 2021, an article published by American college of cardiology stated about the impact of COVID-19 infection on cardiovascular diseases which resulted in the pilot trial of intravenous metoprolol administration to patients with COVID-19–associated ARDS found to be safe, and reduced aggravated lung inflammation, and improved oxygenation in patients, which is expected to impel the usage of metoprolol tartrate in upcoming years.
Browse 45 Market Data Tables and 49 Figures spread through 197 Pages and in-depth TOC on “Global Metoprolol Tartrate Market”- Global Forecast to 2030, Global Metoprolol Tartrate Market, by route of administration (Oral and Injectable) by Application (Hypertension, Cardiovascular, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
To know the latest trends and insights prevalent in the Global Metoprolol Tartrate Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/metoprolol-tartrate-market-5256
Moreover, increasing government initiative for supplying medicines in countries, is expected to drive the global metoprolol tartrate market over the forecast period. For instance, on January 16, 2016, PHARMAC, a Pharmaceutical Management Agency of New Zealand government has awarded of Sole Supply Status to Apotex NZ Limited, a pharmaceutical company to supply Apo-Metoprolol in the community and District Health Board (DHB) hospitals in the new Zealand were company will be funded and other alternative brand allowance (ABA) will be provided to company to supply Apo-Metoprolol in new Zealand.
Key Takeaways of the Global Metoprolol Tartrate Market:
- Global metoprolol tartrate market is expected to exhibit a CAGR of 3.3% during the forecast period, owing to increasing presence of market players at all over the globe is expected to drive growth of the global metoprolol tartrate market during the forecast period. For instance, CTX Lifesciences is an Active Pharmaceutical Ingredient (API) and intermediate manufacturing company headquarter at Gujarat, India. Providing Metoprolol Tartrate for treatment hypertensive in all over the world.
- Major players operating in the global metoprolol tartrate market include Novartis Pharmaceuticals Canada Inc., AstraZeneca Pharma India Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Inc., CTX Life Sciences Pvt. Ltd., Hikma Pharmaceuticals PLC, Validus Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Aurobindo Pharma USA, Sandoz Canada Inc., Apotex Inc., Ipca Laboratories Ltd, and Rubicon Research Pvt. Ltd.
